BCL2 and neoplasm: To date, several studies have shown that the Hh pathway is able to inhibit cell death via upregulating the anti-apoptotic gene Bcl2 in human tumor cells, providing Hh pathway inhibitors as proapoptotic drugs for tumor treatment [25, 26].